Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Noxopharm Ltd V.NOX


Primary Symbol: NOXOF

Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.


OTCPK:NOXOF - Post by User

Post by droz1115on Dec 27, 2013 3:08pm
155 Views
Post# 22040908

About time for a POP!

About time for a POP!I'm relatively new to the junior mining sector, but I could tell the potential in this stock.  Picked it up at 0.085 and holding for the long term.  
Their Marben block has 1.5 million ozs of gold indicated and 600k ozs inferred resources. Their indicated ozs alone were selling for roughly $5 in ground gold.  With more exploration potential and already a good size resource this stock has a long way to go if gold gets back to $1500-$1600 this coming year.  I'm not sure if anyone noticed, but Simon Ridgeway, a member of the Casey's Explorers league joined the board this summer.  If someone of his caliber is joining a small company like this, that shows potential in itself.  Any thought? GLTA   
<< Previous
Bullboard Posts
Next >>